Sanctuary Advisors »

Protalix Biotherapeutics shares owned by Sanctuary Advisors

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Sanctuary Advisors from 13F filings

Historical chart of Sanctuary Advisors investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Sanctuary Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Sanctuary Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $63k 37k 1.69

More positions owned by Sanctuary Advisors

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Meta Platforms Cl A (META)
Ishares Tr Core Total Usd (IUSB)

View all positions for Sanctuary Advisors

Top funds holding Protalix Biotherapeutics

Renaissance Technologies
GSA Capital Partners
Stratos Wealth Partners
BlackRock
Citadel Advisors
Susquehanna International
Orin Green Financial
Northern Trust
Commonwealth Equity Services
Point72 Asia
Jane Street
Bank of America Corporation
Virtu Financial
Sanctuary Advisors
Barclays

View all funds holding Protalix Biotherapeutics